SCHEMBL7142949

SCHEMBL7142949

CC1=Cc2c(-c3ccc(C)cc3C)cccc2C1[Zr](Cl)Cl

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27510585 0.84
SCHEMBL5349452 0.84 LMNA (0.30) LMNA
SCHEMBL27462366 0.82 CHEK1 (0.33)
SCHEMBL6889133 0.81 EDNRB (0.32)
SCHEMBL28878593 0.80 BRD4 (0.33)
SCHEMBL7936740 0.78 POLB (0.34) LMNA
SCHEMBL4946930 0.77 MEN1 (0.32)
SCHEMBL3163967 0.77 BRD4 (0.33)
SCHEMBL4060837 0.76 CA12 (0.33)
SCHEMBL7601711 0.76 GSTP1 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030009046-A1 Preparation of preparing substituted indanones EQUISTAR CHEMICALS, LP 2003-01-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030009046-A1 Preparation of preparing substituted indanones CYP1A2, CYP1B1, CYP1A1 LMNA 1251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.